IRIS
MERCURIO, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.405
EU - Europa 955
AS - Asia 495
AF - Africa 57
SA - Sud America 14
OC - Oceania 1
Totale 2.927
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.389
IT - Italia 657
SG - Singapore 280
CN - Cina 112
NL - Olanda 63
DE - Germania 54
VN - Vietnam 39
CI - Costa d'Avorio 37
IE - Irlanda 28
FR - Francia 27
PT - Portogallo 19
JP - Giappone 18
FI - Finlandia 17
IN - India 17
ES - Italia 16
CA - Canada 12
RU - Federazione Russa 10
BE - Belgio 9
EG - Egitto 9
GB - Regno Unito 8
TR - Turchia 7
BG - Bulgaria 6
CO - Colombia 6
HK - Hong Kong 5
PL - Polonia 5
SE - Svezia 5
AR - Argentina 4
GE - Georgia 4
HR - Croazia 4
LT - Lituania 4
MA - Marocco 4
MX - Messico 4
AT - Austria 3
PH - Filippine 3
PK - Pakistan 3
RS - Serbia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BJ - Benin 2
CH - Svizzera 2
CL - Cile 2
GR - Grecia 2
LV - Lettonia 2
MK - Macedonia 2
NO - Norvegia 2
PE - Perù 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AU - Australia 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
IL - Israele 1
IR - Iran 1
SI - Slovenia 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 2.927
Salva come PNG Salva come JPEG
Città #
Chandler 305
Singapore 219
Ashburn 108
Millbury 71
Naples 71
Lawrence 67
Santa Clara 57
Des Moines 51
Amsterdam 46
Boston 44
Napoli 40
Dong Ket 38
Rome 33
Milan 30
Nanjing 25
Wilmington 23
Palermo 20
Beijing 18
Fairfield 14
Bologna 13
Princeton 13
Shenyang 13
Bari 10
Caserta 10
Catania 10
Council Bluffs 10
Montijo 10
Pune 10
Woodbridge 10
Seattle 9
Chengdu 8
Houston 8
Manfredonia 8
Marcianise 8
Turin 8
Changsha 7
Dublin 7
Hebei 7
Munich 7
Battipaglia 6
Bogotá 6
Brescia 6
Dallas 6
Foggia 6
Menlo Park 6
Nanchang 6
Sofia 6
Cambridge 5
Eindhoven 5
Florence 5
Madrid 5
Ottawa 5
Redwood City 5
Ariano Irpino 4
Cologne 4
Düsseldorf 4
Grottolella 4
Helsinki 4
Hengshui 4
Hong Kong 4
Kronberg 4
Lappeenranta 4
Leawood 4
Locorotondo 4
Oeiras 4
Piemonte 4
Pisa 4
Rho 4
St Petersburg 4
Tbilisi 4
Zagreb 4
Ankara 3
Ann Arbor 3
Chiyoda-ku 3
Guangzhou 3
Jiaxing 3
Lisbon 3
Maasmechelen 3
Marigliano 3
Monmouth Junction 3
Norwalk 3
Paris 3
Perugia 3
Pescara 3
Pisogne 3
Rogliano 3
Toronto 3
Vilnius 3
Alenquer 2
Alexandria 2
Ancona 2
Andria 2
Arzano 2
Augusta 2
Badajoz 2
Bergamo 2
Boardman 2
Borgomanero 2
Cagliari 2
Cairo 2
Totale 1.691
Salva come PNG Salva come JPEG
Nome #
Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice 537
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity 88
Antineoplastic drug-induced cardiotoxicity: A redox perspective 67
Cardiac sympathetic dysfunction in pulmonary arterial hypertension: Lesson from left-sided heart failure 63
Severe Aortic Valve Regurgitation in Relapsing Polychondritis 56
New drugs, therapeutic strategies, and future direction for the treatment of Pulmonary Arterial Hypertension 56
Meccanismi molecolari della cardiotossicità indotta da antracicline e radioterapia 55
Inflammatory, Serological and Vascular Determinants of Cardiovascular Disease in Systemic Lupus Erythematosus Patients 54
Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue 54
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study 50
A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome: A randomized, double-blind, placebo-controlled trial 48
Heart Failure and Cancer: Mechanisms of Old and New Cardiotoxic Drugs in Cancer Patients 48
What is the cardiac impact of chemotherapy and subsequent radiotherapy in lymphoma patients 48
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan 46
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients 46
Adapted recreational football Small Sided Games improves cardiac capacity, body composition and muscular fitness in patients with type 2 diabetes: results from a pilot study 45
Right ventricular failure in left heart disease: from pathophysiology to clinical manifestations and prognosis 44
The use of chest ultrasonography in suspected cases of COVID-19 in the emergency department 44
Time-weighted lactate as a predictor of adverse outcome in acute heart failure 40
Models of Heart Failure Based on the Cardiotoxicity of Anticancer Drugs 39
Oxidative stress in anticancer therapies-related cardiac dysfunction 38
Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEF 38
Novel Therapeutic Approaches and Targets for the Treatment of Cardiovascular and Immunological Diseases 37
Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications 37
Cardiovascular events and treatment of children with high risk medulloblastoma 34
Beta-blockers in pulmonary arterial hypertension: Time for a second thought? 34
Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure 33
Redox imbalances in ageing and metabolic alterations: Implications in cancer and cardiac diseases. An overview from the working group of cardiotoxicity and cardioprotection of the Italian society of cardiology (SIC) 33
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors 33
Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension. 32
Commentary on “Functional Improvement After Outpatient Cardiac Rehabilitation in Acute Coronary Syndrome Patients is not Related to Improvement in Left Ventricular Ejection Fraction” 32
Long-term follow-up in high risk hypertensive patients with carotid dolicoarteriopathies 32
New-Onset Cancer in the HF Population: Epidemiology, Pathophysiology, and Clinical Management 32
Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: A multicenter, double blind, randomized, placebo controlled trial 31
Endocrine alterations are the main determinants of cardiac remodelling in restrictive anorexia nervosa 31
Molecular Mechanisms of Cardiovascular Damage Induced by Anti-HER-2 Therapies 30
Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors 30
Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment 30
Sex-related differences in COVID-19 lethality 30
Effect of Sacubitril-Valsartan in reducing depression in patients with advanced heart failure 30
How can we manage the cardiac toxicity of immune checkpoint inhibitors? 30
Effects of a nutraceutical combination on left ventricular remodeling and vasoreactivity in subjects with the metabolic syndrome 28
Novel metrics for risk stratification with nuclear cardiology 27
Cardiovascular safety of the tyrosine kinase inhibitor nintedanib 27
Sacubitril/valsartan in patients listed for heart transplantation: effect on physical frailty 26
A comprehensive echocardiographic method for risk stratification in pulmonary arterial hypertension 26
Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC) 26
Preventing antiblastic drug-related cardiomyopathy: Old and new therapeutic strategies 25
A nutraceutical combination reduces left ventricular mass in subjects with metabolic syndrome e and left ventricular hypertrophy: A multicenter, randomized, double-blind, placebo-controlled trial 25
Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis 25
Pharmacovigilating cardiotoxicity of immune checkpoint inhibitors 24
Cardiovascular and metabolic effects of Berberine 24
Efficacy and safety of valsartan plus hydroclorothiazide for high blood pressure 23
Metabolomic perspectives in antiblastic cardiotoxicity and cardioprotection 23
Prevention of cancer-therapy-related heart failure 23
Peripheral Vascular Function in Dilated Cardiomyopathy of Different Etiology 23
Prognostic impact of diabetes in chronic and acute heart failure 23
Right ventricular function as assessed by cardiac magnetic resonance imaging-derived strain parameters compared to high-fidelity micromanometer catheter measurements 22
Editorial: Myocardium regeneration and cardioprotection 20
Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors and clinical impact 20
Pulmonary Hypertension Induced by Anticancer Drugs 20
Mildly Elevated Pulmonary Hypertension: Gray Zone or Already a Disease? 19
Mechanisms of Cardiovascular Damage Induced by Traditional Chemotherapy 18
The broad spectrum of cardiotoxicities from immunotherapies 17
Right ventricular dysfunction in chronic heart failure: clinical laboratory and echocardiographic characteristics. (the RIVED-CHF registry) 16
Evaluation of exercise capacity by means of cardiopulmonary exercise testing (CPET) in older adult cancer patients undergoing antineoplastic treatments 16
Blood lactate in mild and moderate ARDS secondary to SARS COV 2 16
Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers 14
Right heart dysfunction: from pathophysiologic insights to therapeutic options: a translational overview 14
Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2 14
Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension 13
Insulin resistance: Is it time for primary prevention? 13
Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction 13
Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension 13
Non-cardiovascular comorbidities in heart failure patients and their impact on prognosis 13
Response to pulmonary vasodilator treatment in a former smoker with combined interstitial lung disease complicated by pulmonary hypertension: Case report and review of the literature 12
The multifaceted mechanisms of nitroxyl in heart failure: inodilator or ‘only’ vasodilator? 12
Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: Application of the ESC/ERS risk prediction model 11
Right ventricular longitudinal strain is diminished in systemic sclerosis compared with idiopathic pulmonary arterial hypertension 11
Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades 11
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function 10
Innovations in medical therapy of heart failure with reduced ejection fraction 10
Phenotyping pulmonary hypertension in systemic sclerosis: a moving target 10
A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome 10
Inflammatory Mechanisms in the Pathogenesis of Pulmonary Arterial Hypertension: Recent Advances 10
Assessment of right ventricular reserve utilizing exercise provocation in systemic sclerosis 10
The right heart in patients with cancer. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology 10
Risk Stratification of Patients with Pulmonary Arterial Hypertension: The Role of Echocardiography 9
Inflammation at the crossroad between cancer and heart failure 8
Cardiovascular Biomarkers in Cardio-Oncology: Antineoplastic Drug Cardiotoxicity and Beyond 8
Lung ultrasound as diagnostic tool for SARS-CoV-2 infection 8
Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy 7
Effect of sacubitril/valsartan on cardiac remodeling compared with other renin-angiotensin system inhibitors: a difference-in-difference analysis of propensity-score matched samples 7
Stress Echocardiographic Prediction of Emerging Pulmonary Vascular Disease in Systemic Sclerosis 7
Essential hypertension worsens left ventricular contractility in systemic sclerosis 7
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension 6
Echocardiographic assessment and clinical implication of functional tricuspid regurgitation in heart failure with reduced or preserved ejection fraction (ECLIPSE-HF) : Rationale and design of the study 6
Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis 6
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension 6
Prevention of cardiovascular complications in elderly cancer patients 6
Totale 3.122
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.448
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202089 0 0 0 0 16 10 10 5 4 7 20 17
2020/2021220 22 14 6 7 35 7 28 8 13 24 12 44
2021/2022432 4 0 6 14 8 12 24 31 27 29 103 174
2022/20231.018 85 67 58 79 114 88 46 130 190 86 49 26
2023/2024663 44 70 73 52 34 81 33 83 20 27 103 43
2024/2025457 145 186 22 43 61 0 0 0 0 0 0 0
Totale 3.130